Analysis | Metabolite Name | Measured Value | Units | Cell Type:BS4 | Stimulation |
---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 1149 | Peak area | TNF-alpha |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 1646 | Peak area | IFN-G |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 1678 | Peak area | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 1951 | Peak area | Untreated |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 2819 | Peak area | IFN-G |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 3782 | Peak area | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 3797 | Peak area | Untreated |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 3961 | Peak area | TNF-alpha |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 4595 | Peak area | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 4960 | Peak area | IL-17A |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 5316 | Peak area | IFN-G |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 6188 | Peak area | TNF-alpha |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | 6639 | Peak area | Untreated |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | Peak area | IL-17A | |
Reversed phase POSITIVE ION MODE | CADAVERINE (CAS# 462-94-2); (M+NA)+ | Peak area | IL-17A |